Genomic Risk Prediction of Coronary Artery Disease in 480,000 Adults Implications for Primary Prevention
By Michael Inouye, Gad Abraham, C. Nelson, Angela M. Wood, Michael J Sweeting, Frank Dudbridge, F. Lai, S. Kaptoge, M. Brozynska, Tingting Wang and 7 more. 2019
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- Gary S. Collins
- Karel G. M. Moons
- Sebastian J. Vollmer
- B. Mateen
- John P. A. Ioannidis
- Gergo Bohner
- Franz J. Király
- Rayid Ghani
Citations in the corpus
- Machine learning and artificial intelligence research for patient benefit: 20 critical questions on transparency, replicability, ethics, and effectiveness (2020, background): “30 Therefore, it is common practice to ascertain not only the complexity of the data, but also the computational resources available, because these resources can be the limiting factor (much more often than with traditional statistical models) in determining what analyses can be undertaken.”
- Genetics of 35 blood and urine biomarkers in the UK Biobank (2021, unknown): “This suggests that the genetic basis of myocardial infarction, as previously reported 74 , already captures the majority of the genetic component of serum lipids and other biomarkers.”